NDC 57894-505 – Darzalex IV
Daratumumab 100 mg/5mL · Injection, Solution, Concentrate · Intravenous
Product NDC57894-505
Product details
- Brand name
- Darzalex IV
- Generic name
- Daratumumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA761036
- Marketed since
- October 15, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD38-directed Cytolytic Antibody
Active ingredients
- Daratumumab 100 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 57894-505-05 | 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE | Oct 15, 2021 |
| 57894-505-20 | 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE | Oct 15, 2021 |